Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00272051
Recruitment Status : Completed
First Posted : January 4, 2006
Last Update Posted : September 13, 2006
Sponsor:
Information provided by:
Sanofi